Thomas Colletti, DHSc, PA-C, DFAAPA
Objective: This review is an investigation of how Aripiprazole (Abilify) compares with other antipsychotics in tic alleviation of patients with a clinical diagnosis of Tourette’s Disorder (TD).
Design: The design is literature review.
Methods: Keywords: “Aripiprazole Tourette’s”. Done on PubMed, Cochrane, and TRIP
Results: There were three studies which met criteria for analysis; Sallee et al1, Lyon et al2 and Zheng et al3.
Conclusion: The systematic review further validates the use of Aripiprazole in the management of tics. Sallee et al1matches it against placebo, and determines the safe and effective dose while Lyon et al2adds patients with comorbidities (OCD+tics, ADHD+tics,) to the cohort
Nyambi EE. TREATMENT OF PEDIATRIC PATIENTS WITH TOURETTE’S DISORDER. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2019; 1(4).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.